EUVIMEDDescoperă EUVIMED
CrossrefCard informativ

Stability and Variability of Symptom Burden in Primary Biliary Cholangitis: Insights From a Decade of Follow‐Up

Akihito Takeuchi, Atsumasa Komori, Kazuhito Kawata, Osamu Yoshida, Kazunari Tanaka, Kazumichi Abe, Yukihisa Fujinaga, Tadashi Namisaki, Naruhiro Kimura, Tomohiro Katsumi, Ryo Miura, Naoko Tachizawa, Yoshinari Asaoka, Yoshiyuki Ueno, Shuji Terai, Hiromasa Ohira, Hitoshi Yoshiji, Kentaro Kikuchi, Takeshi Matsui, Tadashi Ikegami, Akira Honda, Masanori Abe, Atsushi Tanaka

Hepatology Research · 2026-11 · 56 (11) · 1703-1712

DOI: 10.1111/hepr.70246 ↗
RezumatDate bibliografice

Rezumat

ABSTRACT Background and Aims Primary biliary cholangitis (PBC) frequently impairs health‐related quality of life (HRQOL); however, longitudinal changes in symptoms and their relationship with prognosis remain unclear. We aimed to elucidate the current status of symptoms and HRQOL in Japanese patients with PBC, evaluate 10‐year changes in PBC‐40 scores, and examine associations with long‐term outcomes. Methods This multicenter observational study comprised three analyses: (i) a 2025 cross‐sectional study assessing associations between clinical parameters, PBC‐40 (symptom indicators), and EQ‐5D‐5 L (HRQOL indicators); (ii) a longitudinal PBC‐40 study comparing scores from 2015 to 2025; and (iii) a longitudinal outcome study evaluating 2015 PBC‐40 scores and clinical parameters in relation to survival through 2025. Results In 2025%, 20%–50% of all patients ( n = 239) had moderate/severe PBC‐40 scores in each domain. EQ‐5D‐5L scores were significantly lower in women < 59 years versus general population, with multivariable analysis identifying itch, fatigue, and social domains as independent contributors to impaired HRQOL. Across a 10‐year follow‐up, overall significant deterioration was observed in symptoms ( p = 0.0015), itch ( p = 0.0039), and cognitive ( p = 0.0011) domains, while interindividual variability was greatest in itch and emotional and smallest in symptoms. In longitudinal outcome study ( n = 410), no PBC‐40 domain predicted death or liver transplantation. Conclusions HRQOL in patients with PBC was significantly impaired in younger female. Over 10 years, overall and interindividual changes in domain scores greatly varied, suggesting that symptom burdens are driven by heterogeneous underlying mechanisms. HRQOL impairment represents distinct dimensions of disease impact in PBC, independently of long‐term outcomes.

Cunoștințe potrivite muncii dumneavoastră.

De la începutul gratuit și cercetarea bibliografică personală până la Research Suite complet.

Vezi tarifele →

Sunt incluse toate textele integrale ale editorilor?

Nu. Referințele bibliografice, rezumatele și textele integrale sunt conținuturi diferite. Disponibilitatea unui text integral depinde de sursă, de Open Access și de licențele pe care le aveți deja. Un abonament EUVIMED nu înlocuiește drepturile suplimentare ale editorilor.

Vezi tarifele →